Personas / Equipo Humano

F. Xavier Palomer Tarridas

Buscador de publicaciones

Publicaciones

  • Jurado-Aguilar J, Barroso E, Bernard M, Zhang M, Peyman M, Rada P, Valverde ÁM, Wahli W, Palomer FX and Vazquez M.

    GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-ß1/SMAD3 pathway

    METABOLISM-CLINICAL AND EXPERIMENTAL . 152: 155772-155772. Nº de citas: 18

    [doi:10.1016/j.metabol.2023.155772]

  • Peyman M, Barroso E, Turcu AL, Estrany F Jr, Smith D, Jurado-Aguilar J, Rada P, Morisseau C, Hammock BD, Valverde ÁM, Palomer FX, Galdeano C, Vázquez S and Vazquez M.

    Soluble epoxide hydrolase-targeting PROTAC activates AMPK and inhibits endoplasmic reticulum stress

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie . 168: 115667-115667. Nº de citas: 3

    [doi:10.1016/j.biopha.2023.115667]

  • Barroso E, Díaz M, Reguera AC, Peyman M, Balsinde J, Jurado-Aguilar J, Zhang M, Rostami A, Palomer FX, Ibañez-Toda L and Vazquez M.

    CHOP upregulation and dysregulation of the mature form of the SNAT2 amino acid transporter in the placentas from small for gestational age newborns

    CELL COMMUNICATION AND SIGNALING . 21(1): 326-326. Nº de citas: 2

    [doi:10.1186/s12964-023-01352-5]

  • Zhang M, Barroso E, Ruart M, Peña L, Peyman M, Aguilar-Recarte D, Montori M, Rada P, Cugat C, Montironi C, Zarei M, Jurado-Aguilar J, Camins A, Balsinde J, Valverde ÁM, Wahli W, Palomer FX and Vazquez M.

    Elafibranor upregulates the EMT-inducer S100A4 via PPARß/d

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie . 167: 115623-115623. Nº de citas: 11

    [doi:10.1016/j.biopha.2023.115623]

  • Zhang M, Bagán A, Martínez D, Barroso E, Palomer FX, Vázquez S, Escolano C and Vazquez M.

    Design and Synthesis of AMPK Activators and GDF15 Inducers

    Molecules . 28(14): .

    [doi:10.3390/molecules28145468]

  • Barroso E, Montori M, Wahli W, Palomer FX and Vazquez M.

    Striking a gut-liver balance for the antidiabetic effects of metformin

    TRENDS IN PHARMACOLOGICAL SCIENCES . 44(7): 457-473. Nº de citas: 6

    [doi:10.1016/j.tips.2023.04.004]

  • Aguilar-Recarte D, Barroso E, Zhang M, Rada P, Pizarro J, Peña L, Palomer FX, Valverde ÁM, Wahli W and Vazquez M.

    A positive feedback loop between AMPK and GDF15 promotes metformin antidiabetic effects.

    PHARMACOLOGICAL RESEARCH . 187: 106578-106578. Nº de citas: 26

    [doi:10.1016/j.phrs.2022.106578]

  • Aguilar-Recarte D, Barroso E, Palomer FX, Wahli W and Vazquez M.

    Knocking on GDF15?s door for the treatment of type 2 diabetes mellitus

    TRENDS IN ENDOCRINOLOGY AND METABOLISM . 33(11): 741-754. Nº de citas: 27

    [doi:10.1016/j.tem.2022.08.004]

  • Montori M, Aguilar-Recarte D, Zarei M, Pizarro J, Palomer FX and Vazquez M.

    Endoplasmic reticulum stress downregulates PGC-1a in skeletal muscle through ATF4 and an mTOR-mediated reduction of CRTC2

    CELL COMMUNICATION AND SIGNALING . 20(1): 53-53. Nº de citas: 17

    [doi:10.1186/s12964-022-00865-9]

  • Aguilar-Recarte D, Barroso E, Gumá L, Pizarro J, Peña L, Ruart M, Palomer FX, Wahli W and Vazquez M.

    GDF15 mediates the metabolic effects of PPARß/d by activating AMPK.

    CELL REPORTS . 36(6): 109501-109501. Nº de citas: 66

    [doi:10.1016/j.celrep.2021.109501]